David Ewing Duncan is a journalist, author and broadcaster. He most recently published When I'm 164, about the science of radical life extension.
Dobbs writes about the science of behavior and the behavior of scientists and is the author of Reef Madness and the upcoming The Orchid and the Dandelion.
Author of the bestselling The Immortal Life of Henrietta Lacks, Skloot writes about science for the New York Times Magazine and other publications.
The head of the Human Genome Project is a devout Christian and true believer in stem cell research.
Spaniards hope to put an end to a propaganda campaign against their country that began half a millennium ago.
We may be closer than most realize to significant increases in life expectancy.
After using his programming smarts to make billions on Wall Street, a computer scientist is creating a supercomputer capable of unlocking the elemental mysteries of life.
San Francisco is using advanced technology—and the strong arm of government—to turn the city into one of America’s greenest.
Entering the new world of neuroenhancers.
A glimpse into the bold, controversial, and as-of-yet unregulated world of consumer genetic information services.
With so much inconsistency from one firm to the next, can we really trust the next wave of for-profit genetic testing?
NeuroVigil’s iBrain may help people with A.L.S., like Stephen Hawking, communicate using advanced machine-brain interfaces.
The Harvard geneticist George M. Church has co-founded or advises some 22 businesses that focus on things like synthetic biology, genetic sequencing and providing genetic testing to consumers.
Drugs. Implants. Virtual reality. Do we really want joy 24/7?
New biomedical discoveries may bring a steeper increase in life span—but not everyone wants it.
Eric Schadt is one of a handful of scientists blending mathematics, biology and supercomputers to pursue a new understanding of human biology.
Pushing the limits of genetic medicine means testing the limits of human ethics.
For the first time, a paralyzed patient has operated a prosthetic arm using just his mind.
A controversial biologist at Harvard claims he can extend life span and treat diseases of aging. He may be right.
Potent new cancer treatments come with a big catch: They tend to work on just a few people. New ways to match the right drug with the right patient could finally lead to a genuine breakthrough.
Is pond scum the solution to the world’s energy future?
What can heart cells generated from my blood tell me about my risk for disease—and about what drugs I should take if I get sick?
Overweight Micronesians could help explain the genetics of obesity.
America’s wunderkinds once looked to politics to make a difference on issues like healthcare reform. Now they come to Google Ventures asking Bill Maris for money.
The neurotech industry is engaged in a $2 trillion race to fix your brain. Many players will fail, but the payoff will be huge for those who succeed.
Using fMRI technology to track our thoughts on some big questions.